235. Hypoparathyroidism
67 clinical trials,   112 drugs   (DrugBank: 24 drugs),   4 drug target genes,   5 drug target pathways

Searched query = "Hypoparathyroidism", "Accessory thyroid hypergasia disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02652884
(ClinicalTrials.gov)
January 20165/1/2016Steroids in the Postoperative Transient Hypoparathyroidism Total ThyroidectomyEvaluation of Potential Benefits of Using Steroids in the Postoperative Transient Hypoparathyroidism Total ThyroidectomyTransient HypoparathyroidismDrug: phosphate and betamethasone acetate, 2 mL.;Drug: saline 0.9% NaClHospital Italiano de Buenos AiresNULLRecruiting18 YearsN/ABoth110Phase 4Argentina
2JPRN-UMIN000000475
2006/07/0101/09/2006Therapeutic strategy of relative hypoparathyroidism in hemodialysis patients using sevelamer hydrochloride, with special reference to vitamin D administration Relative hypoparathyoidism in maintenance hemodialysis patientsReplacement of calcium carbonate with sevelamer hydrochloride as phosphate binderHokusetsu ROD Study GroupNULLComplete: follow-up complete20years-oldNot applicableMale and Female40Not applicableJapan